Taken together, our findings indicate that miR-105-1 levels may play an essential role in HCC progression by targeting NCOA1 suggesting that NCOA1 and miR-105-1 have potential prognostic value as tumor biomarkers in HCC patients. Here, NCOA1 is linked to hepatocellular carcinoma.